Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans.
Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma.
Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia.
Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 6370 Nancy Ridge Drive, Suite 106, San Diego,ca 92121,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- polarispharma.com
- HQ
- San Diego, CA
Polaris Pharmaceuticals Questions
Polaris Pharmaceuticals's website is polarispharma.com
Polaris Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/polaris-pharmaceuticals
Polaris Pharmaceuticals has
25 employees.
View email and phone details for 25
employees at Polaris Pharmaceuticals.
Polaris Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Polaris Pharmaceuticals's top competitors are
Tabuk Pharmaceuticals Manufacturing Company,
Polaris Pharmaceuticals Inc.,
Polaris Inc.,
Arrowhead Pharmaceuticals,
Lonza,
Travere Therapeutics,
Hikma Pharmaceuticals,
Polaris Pharmacy Services,
Cellarity,
Istari Oncology.
Polaris Pharmaceuticals's categories are Pharmaceutical Manufacturing
Polaris Pharmaceuticals's founding year is 2006
